BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ExoFlo readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ExoFlo\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07625293-50@assetmemo.bio
DTSTAMP:20261121T004012Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:ExoFlo: Phase 2 readout est. (NCT07625293)
DESCRIPTION:ExoFlo\, phase 2\, Crohn's Disease.\nStudy: DB-3Q for the Treat
 ment of Medically Refractory Crohn's Disease\nEstimated primary completion
 : June 2027. This is a ClinicalTrials.gov estimate\, not a confirmed reado
 ut date\, and it can move.\nDrug page: https://assetmemo.bio/drug/exoflo#u
 pcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07625
 293
URL:https://assetmemo.bio/drug/exoflo#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06918808-50@assetmemo.bio
DTSTAMP:20261121T004012Z
DTSTART;VALUE=DATE:20270730
DTEND;VALUE=DATE:20270731
SUMMARY:ExoFlo: Phase 2 readout est. (NCT06918808)
DESCRIPTION:ExoFlo\, phase 2\, Crohn's Disease.\nStudy: DB-3Q bmMSC-EVs in 
 Patients With Perianal Fistulizing Crohn's Disease\nEstimated primary comp
 letion: 30 July 2027. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /exoflo#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT06918808
URL:https://assetmemo.bio/drug/exoflo#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05354141-50@assetmemo.bio
DTSTAMP:20261121T004012Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:ExoFlo: Phase 3 readout est. (NCT05354141)
DESCRIPTION:ExoFlo\, phase 3.\nStudy: Extracellular Vesicle Treatment for A
 cute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)\nEstimated pri
 mary completion: 30 November 2027. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/exoflo#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT05354141
URL:https://assetmemo.bio/drug/exoflo#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
